IDH mutations are more common in secondary glioblastomas and the unique histological features such as microvascular proliferation and necrosis are critical for prognosis, as IDH-mutant GBMs have shorter recurrence-free and overall survival. This evidence concerns the gene IDH2 and glioblastoma.